Astrazeneca India Profile
Key Indicators
- Authorised Capital ₹ 50.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 28.97 Cr
as on 16-11-2024
- Company Age 38 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 44.07%
(FY 2023)
- Profit 85.09%
(FY 2023)
- Ebitda 85.83%
(FY 2023)
- Net Worth 33.28%
(FY 2023)
- Total Assets 35.27%
(FY 2023)
About Astrazeneca India
The Corporate was formerly known as Astra-Idl Biochemicals Pvt Ltd. The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 50.00 Cr and a paid-up capital of Rs 28.97 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Astrazeneca India Private Limited India is Alex Chandy as COMPANY SECRETARY. Sivakumar Padmanabhan, Sanjeev Panchal, and Priyanka Mahadevan serve as directors at the Company.
- CIN/LLPIN
U24111TN1986PTC123423
- Company No.
123423
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Jan 1986
- Date of AGM
27 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Astrazeneca India?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sivakumar Padmanabhan  | Managing Director | 20-Mar-2015 | Current |
Alex Chandy  | Company Secretary | 22-Mar-2016 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sanjeev Panchal | Director | Current | |
| Priyanka Mahadevan | Director | Current |
Financial Performance and Corporate Structure Insights of Astrazeneca India.
Astrazeneca India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 44.07% increase. The company also saw a substantial improvement in profitability, with a 85.09% increase in profit. The company's net worth Soared by an impressive increase of 33.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Astrazeneca India?
In 2023, Astrazeneca India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Astrazeneca India?
Astrazeneca India has a workforce of 3105 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Astrazeneca India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Astrazeneca India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
